Oral surgery, oral medicine, oral pathology and oral radiologyHumansRetrospective StudiesImmune Checkpoint InhibitorsFemaleMale
Orofacial adverse events associated with immune checkpoint inhibitors: using a large real-world dataset.
Stella O Oyewole, Adepitan A Owosho
Published: 202610.1016/j.oooo.2025.09.006
Abstract
BACKGROUND: Immune checkpoint inhibitors (ICIs) represent a promising therapeutic class in oncology, increasingly utilized either alone or alongside chemotherapy/radiotherapy. As their use expands, understanding the spectrum of oral adverse events es…
Preview only. Read the full abstract at the source